Fig. 3

Subgroup analyses for the association between intermittent infusion hemodiafiltration (I-HDF) therapy and mortality BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; HD, hemodialysis; I-HDF, intermittent infusion hemodiafiltration; SBP, systolic blood pressure